Powder Dosage Form

Overview

Powder dosage form, or simply "powder" (散剂, sanji), represents one of the oldest and most versatile pharmaceutical dosage forms in both traditional Chinese medicine and modern pharmacology. This solid dosage form consists of finely divided drug substances, which may be used alone or mixed with appropriate excipients. Powders can be administered orally or applied topically, offering advantages in terms of rapid disintegration, absorption, and flexibility in dosing, particularly for pediatric and geriatric patients.

History

The use of powdered medications dates back to ancient times in various medical traditions. In traditional Chinese medicine (TCM), powders have been utilized for centuries, as evidenced by historical texts like the "Shennong Ben Cao Jing" (神农本草经), which describes medicinal substances in various forms including powders. The ancient Chinese medical maxim "散者妆也，去急病用之" ("Powders are for swift action, used in acute conditions") succinctly captures the historical understanding of powders' rapid therapeutic effects.

Modern pharmaceutical powder formulation has evolved significantly from these traditional preparations, incorporating advanced particle engineering, manufacturing technologies, and quality control standards while maintaining the fundamental advantages of this dosage form.

Key Information

Types and Classification

Powders are classified based on their route of administration:

Oral Powders

Oral powders are typically dissolved or dispersed in water, diluents, or other liquids before administration, though some may be taken directly with water. They can exert either systemic or local therapeutic effects. Common examples include:
- Xiao'er Qingfei San (小儿清肺散, Pediatric Lung-Clearing Powder)
- Liuwei Anxiao San (六味安消散, Six-Ingredient Anxiaoling Powder)
- Shedan Chuanbei San (蛇胆川贝散, Snake Gallbladder Fritillary Bulb Powder)
- Montmorillonite Powder (蒙脱石散剂)
- Polyethylene Glycol 4000 Powder (聚乙二醇4000散剂)

Topical Powders

Topical powders are formulated for application to the skin, oral cavity, throat, or other body cavities. Examples include:
- Calamine powder (痱子粉, prickly heat powder)
- Oral ulcer powder (口腔溃疡散)

Powders specifically designed for therapeutic, preventive, or lubricating purposes for the skin are also referred to as dusting powders or撒布剂 (sabuji).

Characteristics

Powders represent the solid dosage form with the greatest degree of dispersion, characterized by small particle sizes and large specific surface areas. The key characteristics of powders include:

1. Rapid onset of action: Compared to other solid dosage forms, powders disperse easily, dissolve quickly, are absorbed rapidly, and therefore exhibit fast therapeutic effects.

2. Simple preparation: The manufacturing process is relatively straightforward, dosage is easy to control, and they are particularly convenient for administration to infants and young children.

3. Patient acceptance: For drugs requiring large doses, powders are often more acceptable to patients than solid dosage forms like tablets. For example, magnesium trisilicate powder administered at 1-5g per dose is generally better tolerated than tablet formulations.

4. Topical advantages: External powders cover large surface areas and can simultaneously provide protective, astringent, and wound-healing effects for injuries.

5. Disadvantages: Due to their high degree of dispersion, powders may exhibit increased hygroscopicity, odor, irritation, and instability.

Manufacturing Process

The production of pharmaceutical powders involves several critical steps:

Material Preparation

Prior to comminution, solid materials undergo appropriate preparation. For chemical drugs, raw materials are thoroughly dried. For traditional Chinese medicines, herbs are processed according to their properties, including washing, drying, cutting, or preliminary crushing before final comminution.

Comminution

Comminution (粉碎, fensui) significantly reduces the particle size of solid drugs, promoting uniform mixing and improving the dissolution rate of poorly soluble drugs. However, this process may also affect drug properties such as crystal transformation, thermal degradation, particle adhesion, and wettability. Common comminution equipment includes mortars, ball mills, impact mills, and fluid energy mills.

Sieving

Sieving (筛分, shifen) improves material flow properties and ensures uniform mixing. When particle size variations are significant, flowability decreases and uniform mixing becomes difficult. Oscillating sieves and rotary vibrating sieves are commonly used, with the latter offering high separation efficiency suitable for large-scale production.

Mixing

Mixing operations aim to achieve uniform content distribution. In solid mixing, particles are the dispersion units, making molecular-level homogeneity impossible. Therefore, minimizing particle size of components is essential for achieving relative uniformity. The choice of mixing method depends on component characteristics, powder quantities, and available equipment.

For components with large mixing ratios, the geometric dilution method (等量递加混合法) is employed: small quantities of potent ingredients are mixed with equal volumes of other components, with quantities progressively increased until complete homogeneity is achieved. Powders containing small quantities of potent drugs mixed with several-fold diluents are called "multiple dilution powders" (倍散). Common diluents include lactose, sucrose, starch, dextrin, precipitated calcium carbonate, calcium phosphate, and kaolin.

Packaging and Storage

Due to their small particle size and large surface area, powders are prone to instability issues such as caking, discoloration, degradation, or mold formation. Unless otherwise specified, powders should be packaged in impermeable materials and stored in tightly closed containers. Powders containing volatile or hygroscopic substances require sealed storage.

Quality Control

The Chinese Pharmacopoeia 2015 Edition Volume IV General Chapter 0115 specifies quality control tests for powders:

1. Particle size: For chemical drug topical powders, Chinese medicine topical powders for burns or severe wounds, and pediatric powders, particle size and distribution must be determined using the single sieve method. For chemical drugs, not less than 95% by weight should pass through sieve No.7 (120 mesh, 125µm). For Chinese medicines, not less than 95% should pass through sieve No.6 (100 mesh, 150µm).

2. Uniformity of appearance: The powder should show uniform color without花纹 (patterns) or色斑 (color spots) when spread on smooth paper and observed under bright light.

3. Loss on drying: Not more than 2.0% when dried to constant weight at 105°C.

4. Moisture content: For Chinese medicine powders, not more than 9.0% unless otherwise specified.

5. Content uniformity: Single-dose packaged powders must meet content uniformity requirements.

6. Weight variation: Multi-dose packaged powders must comply with minimum weight requirements.

7. Sterility: Topical powders for burns or wounds must be sterile.

8. Microbial limits: Must comply with pharmacopoeial requirements unless otherwise specified.

Cultural Significance

In traditional Chinese medicine, powders hold particular significance due to their rapid onset of action, making them suitable for treating acute conditions. The historical maxim "散者妆也，去急病用之" reflects this understanding. The preparation of powders, especially using traditional methods like water floating (水飞法, shuifeifa) for mineral drugs, represents important pharmaceutical knowledge that has been transmitted through generations of TCM practitioners.

Modern Status

Today, powder dosage forms continue to play an important role in modern pharmacy, particularly for:
- Pediatric patients who have difficulty swallowing solid dosage forms
- Drugs requiring rapid absorption or action
- Topical applications where coverage and absorption are critical
- Large dose medications where patient acceptance of solid forms may be poor

Modern manufacturing technologies have improved powder processing, including controlled particle size distribution, improved mixing techniques, and specialized packaging to enhance stability and patient compliance.

Examples

A traditional Chinese medicine powder formulation illustrates the principles of powder preparation:

Prescription: Borneolum Syntheticum (冰片) 50g, Borax (炒) (Borax, stir-baked) 500g, Cinnabaris (朱砂) 60g, Mirabilite (玄明粉) 50g

Preparation: The four ingredients are processed as follows: Cinnabaris is comminuted to the finest powder using the water floating method; Borax is ground to a fine powder; Borneolum Syntheticum is finely triturated. These powders are then mixed with Mirabilite, passed through a sieve, and blended to uniformity.

Notes:
1. Cinnabaris mainly contains mercury sulfide, occurring in granular or massive form with bright or dark red color and luster. The water floating method yields the finest powder.
2. Mirabilite is obtained from weathered and dried mirabilite (sodium sulfate), containing not less than 99% sodium sulfate.
3. The red color of Cinnabaris facilitates visual assessment of mixing uniformity.
4. The content of Borneolum Syntheticum, determined by ether extraction and gravimetry, should not be less than 3.5%.
5. The water floating method (水飞法) utilizes different suspension properties of coarse and fine powders in water to prepare ultrafine powders from insoluble mineral and shell drugs. The drug is placed in a mortar with water, ground, then more water is added. The coarse powder settles while the fine powder remains suspended. The suspension is decanted, and the process is repeated until the desired fineness is achieved.

References

1. Chinese Pharmacopoeia. 2015 Edition. Volume IV. General Chapter 0115: Powders.

2. Pharmaceutical Dosage Forms and Drug Delivery Systems. Edited by ME Aulton. 9th Edition. Pharmaceutical Press, 2019.

3. Remington: The Science and Practice of Pharmacy. 23rd Edition. Mack Publishing Company, 2021.

4. Traditional Chinese Medicine: Scientific Basis and Clinical Applications. Edited by CP Zandi and S Hadad-Guilani. Springer, 2018.

5. Pharmaceutical Excipients and Technology. Edited by ME Aulton. 3rd Edition. Pharmaceutical Press, 2017.